Skip to main content
All lobbying filings

DLA PIPER LLP (US)

Lobbying for NOVARTIS · Innovative medicines company.

 Filing Registration
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · posted Jun 24, 2025

Official filing document

 Lobbying activity 2
Pharmacy

Federal proposals and policies impacting disease treatment, including: health care policies; Medicare and Medicaid payment, coverage, and reimbursement; drug pricing and supply chain issues; FDA policies and procedures; drug patents and patent reporting requirements; tariffs; tax reform and tax policy; and intellectual property protections and enforcement.

Medical/Disease Research/Clinical Labs

Federal proposals and policies impacting disease treatment, including: health care policies; Medicare and Medicaid payment, coverage, and reimbursement; drug pricing and supply chain issues; FDA policies and procedures; drug patents and patent reporting requirements; tariffs; tax reform and tax policy; and intellectual property protections and enforcement.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem